Fifth District Bancorp insider grant: 11,118 RSUs and 27,797 options disclosed
Rhea-AI Filing Summary
Fifth District Bancorp director Greg Abry acquired equity and option awards on 09/16/2025. The Form 4 shows 11,118 restricted shares of Common Stock were acquired at no cash cost and, after the transaction, Mr. Abry beneficially owns 41,118 shares. In addition, he was granted 27,797 stock options with an exercise price of $13.94 that vest over time and convert into 27,797 shares. Both the restricted shares and the options vest at a rate of 20% per year commencing on 09/16/2026; the options become exercisable beginning 09/16/2026 and expire 09/16/2035. The filing was signed by an agent under power of attorney on 09/17/2025.
Positive
- Director Greg Abry acquired 11,118 restricted shares (no cash price reported) on 09/16/2025
- 27,797 stock options granted with an exercise price of $13.94, exercisable beginning 09/16/2026 and expiring 09/16/2035
- Both restricted shares and options vest at 20% per year commencing 09/16/2026
Negative
- None.
Insights
TL;DR: Director received equity and long-dated options with multi-year vesting, indicating typical alignment through grant-based compensation.
The Form 4 documents a director-level award: 11,118 restricted shares and 27,797 options exercisable at $13.94, vesting 20% per year from 09/16/2026. The multi-year vesting schedule ties value realization to tenure and future performance periods. The option expiration of 09/16/2035 provides a long exercise window. These are standard governance mechanisms to retain and align board members with shareholders, and there is no disclosure here of any cash consideration paid for the restricted shares.
TL;DR: Insider grant is routine; grants create potential future dilution equal to shares underlying options and restricted stock.
The filing reports acquisition of 11,118 restricted shares and 27,797 options (underlying 27,797 shares) at a $13.94 strike, exercisable from 09/16/2026 with expiration 09/16/2035. Combined, these instruments correspond to 38,915 incremental common shares represented in the filing. The document does not state total outstanding shares or grant valuation, so direct dilution impact relative to the company's share count cannot be calculated from this filing alone.